<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00638430</url>
  </required_header>
  <id_info>
    <org_study_id>Humphrey30-2</org_study_id>
    <nct_id>NCT00638430</nct_id>
  </id_info>
  <brief_title>The Effect of Myopic Optical Defocus on the Humphrey Matrix 30-2 Test</brief_title>
  <official_title>The Effect of Myopic Optical Defocus on the Humphrey Matrix 30-2 Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effect of the myopic optical defocus on the
      Humphrey Matrix 30-2 test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Humphery Matrix (Zeiss, Dublin, California, USA; in cooperation with Welch Allyn,
      Skaneateles, New York, USA), which is a recently developed version of FDT perimetry, showed
      more improved technology to detect early glaucomatous damage. The user's guide for the
      Humphrey Matrix (HumphreyÂ® matrix visual field instrument user's guide. Zeiss, Dublin,
      California, USA; in cooperation with Welch Allyn, Skaneateles, New York, USA; 2003) suggests
      that myopic refractive errors more than -3.0 D need to be corrected before the 30-2 test.
      However, the proper correction of the optical defocus is not always easy because of a lack of
      trial frame.

      The purpose of the present study is twofold. At first, the influence of the low-grade myopia
      on the Humphery Matrix 30-2 test will be evaluated and compared to the effect of
      moderate-grade myopia. Secondly, the influence of myopic optical defocus and the glaucomatous
      visual field damage on the pattern deviation plot change according to the severity of
      glaucomatous visual field damage will be estimated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mean defect</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>low myopic group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>moderate myopic group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        tertiary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  intra-ocular pressure 23 or higher

          -  suspicious glaucomatous optic disc change

          -  suspicious defect of retinal nerve fiber layer

          -  or eyes with various degrees of glaucoma

        Exclusion Criteria:

          -  a high myopic eye (SE more than -6.0 D)

          -  moderate to severe cataract

          -  evidence of diabetic or hypertensive retinopathy

          -  macular disease

          -  intra-ocular inflammation

          -  history of intraocular surgery and any other ocular lesion that could have an
             influence on the perimetry result
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>27 Years</minimum_age>
    <maximum_age>61 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Changwon Kee, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Ophthalmology, Samsung Medical Center,</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>130-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Anderson AJ, Johnson CA. Frequency-doubling technology perimetry and optical defocus. Invest Ophthalmol Vis Sci. 2003 Sep;44(9):4147-52.</citation>
    <PMID>12939339</PMID>
  </results_reference>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2008</study_first_submitted>
  <study_first_submitted_qc>March 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2008</study_first_posted>
  <last_update_submitted>March 12, 2008</last_update_submitted>
  <last_update_submitted_qc>March 12, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2008</last_update_posted>
  <responsible_party>
    <name_title>Changwon Kee</name_title>
    <organization>Department of Ophthalmology, Samsung Medical Center,</organization>
  </responsible_party>
  <keyword>myopia</keyword>
  <keyword>Humphery Matrix 30-2 test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

